Choksi Laboratories (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Choksi Laboratories Limited |
|||
|
Price: ₹62.72 | ||
| 52 Week Low: ₹38.32 52 Week High: ₹94.00 |
|||
| Market Capital: 43.29 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Choksi Laboratories Share Price Target For 2024
- 1.1.1: Choksi Laboratories Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Choksi Laboratories Share Price Target For 2025
- 1.2.1: Choksi Laboratories Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Choksi Laboratories Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Choksi Laboratories Financial Performance
- 3.0.1: Is Choksi Laboratories A Good Buy For Long Term?
To predict the Choksi Laboratories's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Choksi Laboratories Share Price Target For 2024
The line chart displays the monthly closing prices of Choksi Laboratories with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Choksi Laboratories shares in 2024, see the table below.
Choksi Laboratories Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 65.89 (+5.05%) | Price Action: 18 Jul 2024 High |
| 2024 Target 2 | 65.17 (+3.9%) | Price Action: May 2024 High |
| 2024 Target 1 | 64.5 (+2.83%) | Price Action: 16 Oct 2023 High |
| Current Price | 62.72 | Choksi Laboratories's share price as of 26 Dec 2024 |
| Stop Loss 1 | 61.9 (-1.31%) | Price Action: 05 Nov 2024 High |
| Stop Loss 2 | 61.28 (-2.29%) | Price Action: 24 Jan 2024 Low |
| Stop Loss 3 | 60.6 (-3.39%) | Price Action: 16 Oct 2023 Low |
Short-Term Technical Outlook
Current Technical Position: Choksi Laboratories is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 50-day moving average at ₹64.44 serves as the nearest technical reference point.
Historical Returns: 3-month: -16.35% | 6-month: +14.04% | 1-year: -7.76%
Choksi Laboratories Share Price Target For 2025
The line chart displays the monthly closing prices of Choksi Laboratories with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Choksi Laboratories shares in 2025, see the table below.
Choksi Laboratories Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 101.75 (+62.22%) | Price Action: Chart |
| 2025 Target 2 | 99.85 (+59.19%) | Price Action: Chart |
| 2025 Target 1 | 98.86 (+57.62%) | Fibonacci Extension Level 64.90% |
| Current Price | 62.72 | Choksi Laboratories's share price as of 26 Dec 2024 |
| Stop Loss 1 | 54.3 (-13.43%) | Price Action: 10 Apr 2024 Low |
| Stop Loss 2 | 53.75 (-14.31%) | Price Action: 28 Aug 2023 High |
| Stop Loss 3 | 53.1 (-15.34%) | Price Action: 02 Jul 2024 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Choksi Laboratories is currently trading at 43.8% of its 52-week range (₹38.32 - ₹94).
Long-Term Trend Analysis: The stock shows mixed long-term signals, trading near key moving averages.
Long-Term Performance: 1-year: -7.76% | 3-year: +187.71% | 5-year: +515.51%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Choksi Laboratories Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹62.72 | ||
| 2024 | ₹64.65 | +3.07% | ₹65.62 |
| 2025 | ₹66.47 | +2.81% | ₹69.05 |
| 2026 | ₹70.75 | +6.43% | ₹71.81 |
| 2027 | ₹68.68 | -2.92% | ₹70.75 |
| 2028 | ₹69.55 | +1.26% | ₹72.46 |
| 2029 | ₹71.14 | +2.28% | ₹74.17 |
| 2030 | ₹73.02 | +2.64% | ₹75.88 |
| 2031 | ₹77.59 | +6.25% | ₹78.75 |
| 2032 | ₹75.19 | -3.09% | ₹77.50 |
| 2033 | ₹76.01 | +1.09% | ₹79.29 |
| 2034 | ₹77.63 | +2.13% | ₹81.00 |
| 2035 | ₹79.56 | +2.48% | ₹82.71 |
| 2036 | ₹84.42 | +6.1% | ₹85.69 |
| 2037 | ₹81.70 | -3.22% | ₹84.26 |
| 2038 | ₹82.48 | +0.95% | ₹86.13 |
| 2039 | ₹81.69 | -0.95% | ₹87.83 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Choksi Laboratories Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 43.29 Crore | Market valuation of Choksi Laboratories's shares. |
| Revenue (TTM) | 36.69 Crore | Total revenue generated by Choksi Laboratories over the past twelve months. |
| Net Income (TTM) | +1.1 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +12.72% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +83.58% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-3.46% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
1.39 | Company's total debt divided by total shareholder equity. |
| Total Debt | 30.87 Crore | Sum of Choksi Laboratories's current & long-term financial obligations. |
Is Choksi Laboratories A Good Buy For Long Term?
Choksi Laboratories, a small-cap stock with a market capitalization of ₹43.29 crore, presents a mixed outlook. While its past 3-5 year returns are impressive (548.52% and 276.81% respectively), recent performance shows a decline (-13.07% in the past 3 months, -9.40% YTD). The high profit margin (83.58%) is positive, but a significant debt of ₹30.87 crore (Q1 2024-25) and a negative revenue change (-3.46%) compared to the previous quarter raise concerns. Given these conflicting signals, Choksi Laboratories is a risky investment; it's not a good buy for the long term for risk-averse investors.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
